Veterinary Drug Industry Research Report 2023
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
Highlights
The global Veterinary Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug.
The Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Veterinary Drug type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Veterinary Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Veterinary Drug segment by Type
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Veterinary Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Veterinary Drug market.
Veterinary Drug segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Veterinary Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Veterinary Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Veterinary Drug market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Veterinary Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drug.
The Veterinary Drug market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Veterinary Drug market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Zoetis
- Elanco
- Boehringer Ingelheim
- Merck
- Virbac
- Ceva
- Vetoquinol
- Dechra
- Norbrook
- Phibro
- Huvepharma
- Hipra
- Ouro Fino Saude
- CAHIC
- Orion
- Ringpu Biology
- Nippon Zenyaku Kogyo
- Farmavet-Pasteur
Global markets are presented by Veterinary Drug type, along with growth forecasts through 2029. Estimates on sales and revenue are based on the price in the supply chain at which the Veterinary Drug are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Veterinary Drug segment by Type
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
This report has provided the market size (sales and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Veterinary Drug market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Veterinary Drug market.
Veterinary Drug segment by Application
- Pets
- Cattle
- Poultry
- Swine
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Veterinary Drug market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Veterinary Drug industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Frequently Asked Questions
- Which product segment grabbed the largest share in the Product Name market?
- How is the competitive scenario of the Product Name market?
- Which are the key factors aiding the Product Name market growth?
- Which are the prominent players in the Product Name market?
- Which region holds the maximum share in the Product Name market?
- What will be the CAGR of the Product Name market during the forecast period?
- Which application segment emerged as the leading segment in the Product Name market?
- What key trends are likely to emerge in the Product Name market in the coming years?
- What will be the Product Name market size by 2028?
- Which company held the largest share in the Product Name market?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Veterinary Drug Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Veterinary Drug Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Veterinary Drug Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Veterinary Drug Revenue of Manufacturers (2018-2023)
Table 9. Global Veterinary Drug Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Veterinary Drug Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Veterinary Drug Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Veterinary Drug, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Zoetis Company Information
Table 17. Zoetis Business Overview
Table 18. Zoetis Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. Zoetis Veterinary Drug Product Portfolio
Table 20. Zoetis Recent Developments
Table 21. Elanco Company Information
Table 22. Elanco Business Overview
Table 23. Elanco Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. Elanco Veterinary Drug Product Portfolio
Table 25. Elanco Recent Developments
Table 26. Boehringer Ingelheim Company Information
Table 27. Boehringer Ingelheim Business Overview
Table 28. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. Boehringer Ingelheim Veterinary Drug Product Portfolio
Table 30. Boehringer Ingelheim Recent Developments
Table 31. Merck Company Information
Table 32. Merck Business Overview
Table 33. Merck Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Merck Veterinary Drug Product Portfolio
Table 35. Merck Recent Developments
Table 36. Virbac Company Information
Table 37. Virbac Business Overview
Table 38. Virbac Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Virbac Veterinary Drug Product Portfolio
Table 40. Virbac Recent Developments
Table 41. Ceva Company Information
Table 42. Ceva Business Overview
Table 43. Ceva Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. Ceva Veterinary Drug Product Portfolio
Table 45. Ceva Recent Developments
Table 46. Vetoquinol Company Information
Table 47. Vetoquinol Business Overview
Table 48. Vetoquinol Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. Vetoquinol Veterinary Drug Product Portfolio
Table 50. Vetoquinol Recent Developments
Table 51. Dechra Company Information
Table 52. Dechra Business Overview
Table 53. Dechra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 54. Dechra Veterinary Drug Product Portfolio
Table 55. Dechra Recent Developments
Table 56. Norbrook Company Information
Table 57. Norbrook Business Overview
Table 58. Norbrook Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Norbrook Veterinary Drug Product Portfolio
Table 60. Norbrook Recent Developments
Table 61. Phibro Company Information
Table 62. Phibro Business Overview
Table 63. Phibro Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 64. Phibro Veterinary Drug Product Portfolio
Table 65. Phibro Recent Developments
Table 66. Huvepharma Company Information
Table 67. Huvepharma Business Overview
Table 68. Huvepharma Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 69. Huvepharma Veterinary Drug Product Portfolio
Table 70. Huvepharma Recent Developments
Table 71. Hipra Company Information
Table 72. Hipra Business Overview
Table 73. Hipra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 74. Hipra Veterinary Drug Product Portfolio
Table 75. Hipra Recent Developments
Table 76. Ouro Fino Saude Company Information
Table 77. Ouro Fino Saude Business Overview
Table 78. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 79. Ouro Fino Saude Veterinary Drug Product Portfolio
Table 80. Ouro Fino Saude Recent Developments
Table 81. CAHIC Company Information
Table 82. CAHIC Business Overview
Table 83. CAHIC Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. CAHIC Veterinary Drug Product Portfolio
Table 85. CAHIC Recent Developments
Table 86. Orion Company Information
Table 87. Orion Business Overview
Table 88. Orion Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Orion Veterinary Drug Product Portfolio
Table 90. Orion Recent Developments
Table 91. Ringpu Biology Company Information
Table 92. Ringpu Biology Business Overview
Table 93. Ringpu Biology Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. Ringpu Biology Veterinary Drug Product Portfolio
Table 95. Ringpu Biology Recent Developments
Table 96. Nippon Zenyaku Kogyo Company Information
Table 97. Nippon Zenyaku Kogyo Business Overview
Table 98. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
Table 100. Nippon Zenyaku Kogyo Recent Developments
Table 101. Farmavet-Pasteur Company Information
Table 102. Farmavet-Pasteur Business Overview
Table 103. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. Farmavet-Pasteur Veterinary Drug Product Portfolio
Table 105. Farmavet-Pasteur Recent Developments
Table 106. Global Veterinary Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Global Veterinary Drug Sales by Region (2018-2023) & (M Units)
Table 108. Global Veterinary Drug Sales Market Share by Region (2018-2023)
Table 109. Global Veterinary Drug Sales by Region (2024-2029) & (M Units)
Table 110. Global Veterinary Drug Sales Market Share by Region (2024-2029)
Table 111. Global Veterinary Drug Revenue by Region (2018-2023) & (US$ Million)
Table 112. Global Veterinary Drug Revenue Market Share by Region (2018-2023)
Table 113. Global Veterinary Drug Revenue by Region (2024-2029) & (US$ Million)
Table 114. Global Veterinary Drug Revenue Market Share by Region (2024-2029)
Table 115. North America Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. North America Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 117. North America Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 118. North America Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 119. North America Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 120. Europe Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Europe Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 122. Europe Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 123. Europe Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 124. Europe Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 125. Asia Pacific Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 126. Asia Pacific Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 127. Asia Pacific Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 128. Asia Pacific Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 129. Asia Pacific Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 130. Latin America Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. Latin America Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 132. Latin America Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 133. Latin America Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 134. Latin America Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 135. Middle East and Africa Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Middle East and Africa Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 137. Middle East and Africa Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 138. Middle East and Africa Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 139. Middle East and Africa Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 140. Global Veterinary Drug Sales by Type (2018-2023) & (M Units)
Table 141. Global Veterinary Drug Sales by Type (2024-2029) & (M Units)
Table 142. Global Veterinary Drug Sales Market Share by Type (2018-2023)
Table 143. Global Veterinary Drug Sales Market Share by Type (2024-2029)
Table 144. Global Veterinary Drug Revenue by Type (2018-2023) & (US$ Million)
Table 145. Global Veterinary Drug Revenue by Type (2024-2029) & (US$ Million)
Table 146. Global Veterinary Drug Revenue Market Share by Type (2018-2023)
Table 147. Global Veterinary Drug Revenue Market Share by Type (2024-2029)
Table 148. Global Veterinary Drug Price by Type (2018-2023) & (USD/Unit)
Table 149. Global Veterinary Drug Price by Type (2024-2029) & (USD/Unit)
Table 150. Global Veterinary Drug Sales by Application (2018-2023) & (M Units)
Table 151. Global Veterinary Drug Sales by Application (2024-2029) & (M Units)
Table 152. Global Veterinary Drug Sales Market Share by Application (2018-2023)
Table 153. Global Veterinary Drug Sales Market Share by Application (2024-2029)
Table 154. Global Veterinary Drug Revenue by Application (2018-2023) & (US$ Million)
Table 155. Global Veterinary Drug Revenue by Application (2024-2029) & (US$ Million)
Table 156. Global Veterinary Drug Revenue Market Share by Application (2018-2023)
Table 157. Global Veterinary Drug Revenue Market Share by Application (2024-2029)
Table 158. Global Veterinary Drug Price by Application (2018-2023) & (USD/Unit)
Table 159. Global Veterinary Drug Price by Application (2024-2029) & (USD/Unit)
Table 160. Key Raw Materials
Table 161. Raw Materials Key Suppliers
Table 162. Veterinary Drug Distributors List
Table 163. Veterinary Drug Customers List
Table 164. Veterinary Drug Industry Trends
Table 165. Veterinary Drug Industry Drivers
Table 166. Veterinary Drug Industry Restraints
Table 167. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Veterinary Drug Volume and Revenue Market Size and CAGR of Manufacturers (2018 Versus 2022)
Table 6. Global Veterinary Drug Sales (M Units) of Manufacturers (2018-2023)
Table 7. Global Veterinary Drug Sales Market Share by Manufacturers (2018-2023)
Table 8. Global Veterinary Drug Revenue of Manufacturers (2018-2023)
Table 9. Global Veterinary Drug Revenue Share by Manufacturers (2018-2023)
Table 10. Global Market Veterinary Drug Average Price (USD/Unit) of Manufacturers (2018-2023)
Table 11. Global Veterinary Drug Industry Ranking, 2021 VS 2022 VS 2023
Table 12. Global Manufacturers of Veterinary Drug, Product Type & Application
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Veterinary Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 16. Zoetis Company Information
Table 17. Zoetis Business Overview
Table 18. Zoetis Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 19. Zoetis Veterinary Drug Product Portfolio
Table 20. Zoetis Recent Developments
Table 21. Elanco Company Information
Table 22. Elanco Business Overview
Table 23. Elanco Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 24. Elanco Veterinary Drug Product Portfolio
Table 25. Elanco Recent Developments
Table 26. Boehringer Ingelheim Company Information
Table 27. Boehringer Ingelheim Business Overview
Table 28. Boehringer Ingelheim Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 29. Boehringer Ingelheim Veterinary Drug Product Portfolio
Table 30. Boehringer Ingelheim Recent Developments
Table 31. Merck Company Information
Table 32. Merck Business Overview
Table 33. Merck Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 34. Merck Veterinary Drug Product Portfolio
Table 35. Merck Recent Developments
Table 36. Virbac Company Information
Table 37. Virbac Business Overview
Table 38. Virbac Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 39. Virbac Veterinary Drug Product Portfolio
Table 40. Virbac Recent Developments
Table 41. Ceva Company Information
Table 42. Ceva Business Overview
Table 43. Ceva Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 44. Ceva Veterinary Drug Product Portfolio
Table 45. Ceva Recent Developments
Table 46. Vetoquinol Company Information
Table 47. Vetoquinol Business Overview
Table 48. Vetoquinol Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 49. Vetoquinol Veterinary Drug Product Portfolio
Table 50. Vetoquinol Recent Developments
Table 51. Dechra Company Information
Table 52. Dechra Business Overview
Table 53. Dechra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 54. Dechra Veterinary Drug Product Portfolio
Table 55. Dechra Recent Developments
Table 56. Norbrook Company Information
Table 57. Norbrook Business Overview
Table 58. Norbrook Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 59. Norbrook Veterinary Drug Product Portfolio
Table 60. Norbrook Recent Developments
Table 61. Phibro Company Information
Table 62. Phibro Business Overview
Table 63. Phibro Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 64. Phibro Veterinary Drug Product Portfolio
Table 65. Phibro Recent Developments
Table 66. Huvepharma Company Information
Table 67. Huvepharma Business Overview
Table 68. Huvepharma Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 69. Huvepharma Veterinary Drug Product Portfolio
Table 70. Huvepharma Recent Developments
Table 71. Hipra Company Information
Table 72. Hipra Business Overview
Table 73. Hipra Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 74. Hipra Veterinary Drug Product Portfolio
Table 75. Hipra Recent Developments
Table 76. Ouro Fino Saude Company Information
Table 77. Ouro Fino Saude Business Overview
Table 78. Ouro Fino Saude Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 79. Ouro Fino Saude Veterinary Drug Product Portfolio
Table 80. Ouro Fino Saude Recent Developments
Table 81. CAHIC Company Information
Table 82. CAHIC Business Overview
Table 83. CAHIC Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. CAHIC Veterinary Drug Product Portfolio
Table 85. CAHIC Recent Developments
Table 86. Orion Company Information
Table 87. Orion Business Overview
Table 88. Orion Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Orion Veterinary Drug Product Portfolio
Table 90. Orion Recent Developments
Table 91. Ringpu Biology Company Information
Table 92. Ringpu Biology Business Overview
Table 93. Ringpu Biology Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. Ringpu Biology Veterinary Drug Product Portfolio
Table 95. Ringpu Biology Recent Developments
Table 96. Nippon Zenyaku Kogyo Company Information
Table 97. Nippon Zenyaku Kogyo Business Overview
Table 98. Nippon Zenyaku Kogyo Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
Table 100. Nippon Zenyaku Kogyo Recent Developments
Table 101. Farmavet-Pasteur Company Information
Table 102. Farmavet-Pasteur Business Overview
Table 103. Farmavet-Pasteur Veterinary Drug Sales (M Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. Farmavet-Pasteur Veterinary Drug Product Portfolio
Table 105. Farmavet-Pasteur Recent Developments
Table 106. Global Veterinary Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 107. Global Veterinary Drug Sales by Region (2018-2023) & (M Units)
Table 108. Global Veterinary Drug Sales Market Share by Region (2018-2023)
Table 109. Global Veterinary Drug Sales by Region (2024-2029) & (M Units)
Table 110. Global Veterinary Drug Sales Market Share by Region (2024-2029)
Table 111. Global Veterinary Drug Revenue by Region (2018-2023) & (US$ Million)
Table 112. Global Veterinary Drug Revenue Market Share by Region (2018-2023)
Table 113. Global Veterinary Drug Revenue by Region (2024-2029) & (US$ Million)
Table 114. Global Veterinary Drug Revenue Market Share by Region (2024-2029)
Table 115. North America Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 116. North America Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 117. North America Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 118. North America Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 119. North America Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 120. Europe Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 121. Europe Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 122. Europe Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 123. Europe Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 124. Europe Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 125. Asia Pacific Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 126. Asia Pacific Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 127. Asia Pacific Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 128. Asia Pacific Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 129. Asia Pacific Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 130. Latin America Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 131. Latin America Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 132. Latin America Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 133. Latin America Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 134. Latin America Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 135. Middle East and Africa Veterinary Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 136. Middle East and Africa Veterinary Drug Sales by Country (2018-2023) & (M Units)
Table 137. Middle East and Africa Veterinary Drug Sales by Country (2024-2029) & (M Units)
Table 138. Middle East and Africa Veterinary Drug Revenue by Country (2018-2023) & (US$ Million)
Table 139. Middle East and Africa Veterinary Drug Revenue by Country (2024-2029) & (US$ Million)
Table 140. Global Veterinary Drug Sales by Type (2018-2023) & (M Units)
Table 141. Global Veterinary Drug Sales by Type (2024-2029) & (M Units)
Table 142. Global Veterinary Drug Sales Market Share by Type (2018-2023)
Table 143. Global Veterinary Drug Sales Market Share by Type (2024-2029)
Table 144. Global Veterinary Drug Revenue by Type (2018-2023) & (US$ Million)
Table 145. Global Veterinary Drug Revenue by Type (2024-2029) & (US$ Million)
Table 146. Global Veterinary Drug Revenue Market Share by Type (2018-2023)
Table 147. Global Veterinary Drug Revenue Market Share by Type (2024-2029)
Table 148. Global Veterinary Drug Price by Type (2018-2023) & (USD/Unit)
Table 149. Global Veterinary Drug Price by Type (2024-2029) & (USD/Unit)
Table 150. Global Veterinary Drug Sales by Application (2018-2023) & (M Units)
Table 151. Global Veterinary Drug Sales by Application (2024-2029) & (M Units)
Table 152. Global Veterinary Drug Sales Market Share by Application (2018-2023)
Table 153. Global Veterinary Drug Sales Market Share by Application (2024-2029)
Table 154. Global Veterinary Drug Revenue by Application (2018-2023) & (US$ Million)
Table 155. Global Veterinary Drug Revenue by Application (2024-2029) & (US$ Million)
Table 156. Global Veterinary Drug Revenue Market Share by Application (2018-2023)
Table 157. Global Veterinary Drug Revenue Market Share by Application (2024-2029)
Table 158. Global Veterinary Drug Price by Application (2018-2023) & (USD/Unit)
Table 159. Global Veterinary Drug Price by Application (2024-2029) & (USD/Unit)
Table 160. Key Raw Materials
Table 161. Raw Materials Key Suppliers
Table 162. Veterinary Drug Distributors List
Table 163. Veterinary Drug Customers List
Table 164. Veterinary Drug Industry Trends
Table 165. Veterinary Drug Industry Drivers
Table 166. Veterinary Drug Industry Restraints
Table 167. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Veterinary DrugProduct Picture
Figure 5. Global Veterinary Drug Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Veterinary Drug Market Size (2018-2029) & (US$ Million)
Figure 7. Global Veterinary Drug Sales (2018-2029) & (M Units)
Figure 8. Global Veterinary Drug Average Price (USD/Unit) & (2018-2029)
Figure 9. Anti-Infectives Product Picture
Figure 10. Anti-Inflammatory Product Picture
Figure 11. Parasiticides Product Picture
Figure 12. Analgesics Product Picture
Figure 13. Sedatives Product Picture
Figure 14. Others Product Picture
Figure 15. Pets Product Picture
Figure 16. Cattle Product Picture
Figure 17. Poultry Product Picture
Figure 18. Swine Product Picture
Figure 19. Others Product Picture
Figure 20. Global Veterinary Drug Revenue Share by Manufacturers in 2022
Figure 21. Global Manufacturers of Veterinary Drug, Manufacturing Sites & Headquarters
Figure 22. Global Manufacturers of Veterinary Drug, Date of Enter into This Industry
Figure 23. Global Top 5 and 10 Veterinary Drug Players Market Share by Revenue in 2022
Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 25. Global Veterinary Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. Global Veterinary Drug Sales by Region in 2022
Figure 27. Global Veterinary Drug Revenue by Region in 2022
Figure 28. North America Veterinary Drug Market Size by Country in 2022
Figure 29. North America Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 30. North America Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 31. United States Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Canada Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Europe Veterinary Drug Market Size by Country in 2022
Figure 34. Europe Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 35. Europe Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 36. Germany Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. France Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. U.K. Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Italy Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Russia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Asia Pacific Veterinary Drug Market Size by Country in 2022
Figure 42. Asia Pacific Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 43. Asia Pacific Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 44. China Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Japan Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. South Korea Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. India Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Australia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. China Taiwan Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Indonesia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Thailand Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Malaysia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Latin America Veterinary Drug Market Size by Country in 2022
Figure 54. Latin America Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 55. Latin America Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 56. Mexico Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Brazil Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Argentina Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Middle East and Africa Veterinary Drug Market Size by Country in 2022
Figure 60. Middle East and Africa Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 61. Middle East and Africa Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 62. Turkey Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 63. Saudi Arabia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 64. UAE Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 65. Global Veterinary Drug Sales Market Share by Type (2018-2029)
Figure 66. Global Veterinary Drug Revenue Market Share by Type (2018-2029)
Figure 67. Global Veterinary Drug Price (USD/Unit) by Type (2018-2029)
Figure 68. Global Veterinary Drug Sales Market Share by Application (2018-2029)
Figure 69. Global Veterinary Drug Revenue Market Share by Application (2018-2029)
Figure 70. Global Veterinary Drug Price (USD/Unit) by Application (2018-2029)
Figure 71. Veterinary Drug Value Chain
Figure 72. Veterinary Drug Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Veterinary Drug Industry Opportunities and Challenges
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Veterinary DrugProduct Picture
Figure 5. Global Veterinary Drug Revenue (US$ Million), 2018 VS 2022 VS 2029
Figure 6. Global Veterinary Drug Market Size (2018-2029) & (US$ Million)
Figure 7. Global Veterinary Drug Sales (2018-2029) & (M Units)
Figure 8. Global Veterinary Drug Average Price (USD/Unit) & (2018-2029)
Figure 9. Anti-Infectives Product Picture
Figure 10. Anti-Inflammatory Product Picture
Figure 11. Parasiticides Product Picture
Figure 12. Analgesics Product Picture
Figure 13. Sedatives Product Picture
Figure 14. Others Product Picture
Figure 15. Pets Product Picture
Figure 16. Cattle Product Picture
Figure 17. Poultry Product Picture
Figure 18. Swine Product Picture
Figure 19. Others Product Picture
Figure 20. Global Veterinary Drug Revenue Share by Manufacturers in 2022
Figure 21. Global Manufacturers of Veterinary Drug, Manufacturing Sites & Headquarters
Figure 22. Global Manufacturers of Veterinary Drug, Date of Enter into This Industry
Figure 23. Global Top 5 and 10 Veterinary Drug Players Market Share by Revenue in 2022
Figure 24. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 25. Global Veterinary Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. Global Veterinary Drug Sales by Region in 2022
Figure 27. Global Veterinary Drug Revenue by Region in 2022
Figure 28. North America Veterinary Drug Market Size by Country in 2022
Figure 29. North America Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 30. North America Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 31. United States Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Canada Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Europe Veterinary Drug Market Size by Country in 2022
Figure 34. Europe Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 35. Europe Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 36. Germany Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. France Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. U.K. Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Italy Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Russia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Asia Pacific Veterinary Drug Market Size by Country in 2022
Figure 42. Asia Pacific Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 43. Asia Pacific Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 44. China Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Japan Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. South Korea Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. India Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Australia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. China Taiwan Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Indonesia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Thailand Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Malaysia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Latin America Veterinary Drug Market Size by Country in 2022
Figure 54. Latin America Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 55. Latin America Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 56. Mexico Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Brazil Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. Argentina Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Middle East and Africa Veterinary Drug Market Size by Country in 2022
Figure 60. Middle East and Africa Veterinary Drug Sales Market Share by Country (2018-2029)
Figure 61. Middle East and Africa Veterinary Drug Revenue Market Share by Country (2018-2029)
Figure 62. Turkey Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 63. Saudi Arabia Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 64. UAE Veterinary Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 65. Global Veterinary Drug Sales Market Share by Type (2018-2029)
Figure 66. Global Veterinary Drug Revenue Market Share by Type (2018-2029)
Figure 67. Global Veterinary Drug Price (USD/Unit) by Type (2018-2029)
Figure 68. Global Veterinary Drug Sales Market Share by Application (2018-2029)
Figure 69. Global Veterinary Drug Revenue Market Share by Application (2018-2029)
Figure 70. Global Veterinary Drug Price (USD/Unit) by Application (2018-2029)
Figure 71. Veterinary Drug Value Chain
Figure 72. Veterinary Drug Production Mode & Process
Figure 73. Direct Comparison with Distribution Share
Figure 74. Distributors Profiles
Figure 75. Veterinary Drug Industry Opportunities and Challenges
